Nuvation Bio Inc (NYSE:NUVB) price on Thursday, May 01, rose 0.89% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.27.
A look at the stock’s price movement, the close in the last trading session was $2.25, moving within a range at $2.2003 and $2.29. The beta value (5-Year monthly) was 1.469. Turning to its 52-week performance, $3.97 and $1.54 were the 52-week high and 52-week low respectively. Overall, NUVB moved 29.71% over the past month.
Nuvation Bio Inc’s market cap currently stands at around $771.04 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-05.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 14.29M, representing a 81.52% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that NUVB is a 25% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend NUVB as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
NUVB’s current price about 15.11% and 14.88% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 66.02, while 7-day volatility ratio is 4.77% and 8.79% in the 30-day chart. Further, Nuvation Bio Inc (NUVB) has a beta value of 1.42, and an average true range (ATR) of 0.14. Analysts have given the company’s stock an average 52-week price target of $6, forecast between a low of $6 and high of $6. Looking at the price targets, the low is -164.32% off current price level while to achieve the yearly target high, price needs to move -164.32%. Nonetheless, investors will most likely welcome a -164.32% jump to $6 which is the analysts’ median price.
If we refocus on Nuvation Bio Inc (NYSE:NUVB), historical trading data shows that trading volumes averaged 2.67 over the past 10 days and 2.74 million over the past 3 months. The company’s latest data on shares outstanding shows there are 336.84 million shares.
The 33.21% of Nuvation Bio Inc’s shares are in the hands of company insiders while institutional holders own 45.47% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 30.81 million on 2025-04-15, giving us a short ratio of 10.26. The data shows that as of 2025-04-15 short interest in Nuvation Bio Inc (NUVB) stood at 1487.0 of shares outstanding, with shares short rising to 28.39 million registered in 2025-03-14. Current price change has pushed the stock -14.66% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the NUVB stock continues to rise going into the next quarter.
